NewAmsterdam Pharma

Alzheimers research brain scientist magnifying glass questions neuro

NewAmsterdam links lipid drug to drop in Alzheimer's biomarker

The phase 3 sub-study tracked significant changes in an biomarker, adding to evidence that CETP inhibition may cut the risk of developing Alzheimer’s.

Nick Paul Taylor Jun 9, 2025 8:25am

heart cardiovascular check up stethescope

NewAmsterdam shares sign drug improves cardiovascular outcomes

Dec 10, 2024 8:48am

NewAmsterdam’s cholesterol ph. 3 hits, but disappoints investors

Nov 20, 2024 10:07am

NewAmsterdam drug cuts cholesterol, but by less than expected

Jul 29, 2024 8:00am

NewAmsterdam shares more data on lipid-lowering Amgen castoff

Apr 9, 2024 5:30am

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am